Documents & Downloads

BDCRB

HCMV Inhibitor

BDCRB is a selective inhibitor of Human cytomegalovirus (HCMV) that targets the viral life cycle by blocking the maturational cleavage of high-molecular-weight DNA. This compound demonstrates effective antiviral activity with a mean IC50 of 0.03 μM for viral yield at 72 hours post-infection. BDCRB can be utilized in research focused on HCMV replication and its impact on host cell biology.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	142356-43-2
Applications	HCMV Inhibitor
Formula	C₁₂H₁₁BrCl₂N₂O₄
Molecular Weight	398.04
Synonyms	2-Bromo-5,6-dichloro-1-β-D-ribofuranosyl benzimidazole
SMILES	O[C@H]1[C@H](N2C3=CC(Cl)=C(Cl)C=C3N=C2Br)O[C@H](CO)[C@H]1O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.